Updated Diagnostic Criteria for Alzheimer’s Disease: Implications for Clinical Trials

The improvement of Alzheimer's clinical trial patient access through diagnostic criteria

Read more

This article will review the importance of early detection in emerging markets characterised by a predominance of undiagnosed cases, and the impact of new criteria on drug development in terms of trial design, conduct, and subject selection in Alzheimer’s Disease (AD) trials.


Chief Development Officer

Want to learn more about Worldwide Clinical Trials?